KALV Financials
Kalvista Pharmaceuticals Inc - Financial statements & key metrics
Stock Price
$20.48
Market Cap
$1.00B
EPS
$-3.94
Income Statement Highlights
Most Recent Quarter: 2025-04-30
Revenue
-
Gross Profit
-
Operating Income
-
Net Income
$-183.44M
EPS (Diluted)
$-3.69
Balance Sheet Highlights
Total Assets
$250.77M
Total Liabilities
-
Shareholders Equity
-
Cash & Equivalents
$131.62M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-152.91M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Gross Margin
25.7%
Operating Margin
-0.2%
Net Margin
-2.2%
ROE
-1.9%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is KALV revenue?
View KALV's income statement for detailed revenue data.
Is KALV profitable?
KALV reported a loss of $183.44M in the most recent quarter. The net profit margin is -2.2%.
What is KALV market cap?
KALV has a market capitalization of $1.00B, making it a small-cap stock.
Does KALV have debt?
View KALV's balance sheet for debt information.
What is KALV cash flow?
Cash flow data is available in the full financial statements.